...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZEN003694 Trial is now recruiting patients

The status of the ZEN003694 trial NCT02705469: A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer was updated on 4/30/16 and is now showing 3 sites as recruiting patients. The 2 new sites are University of California San Francisco Medical Center and Memorial Sloan Kettering Cancer Center in NY in addition to Oregon Health and Science University in Portland, OR, which was already recruiting. Four other sites are not recruiting yet.

Thanks to RVX_Anonymous on the SH board for first posting.

BearDownAZ

Share
New Message
Please login to post a reply